Abstract
Four new cycloartane glycosides, 3-O-β-d-xylopyranosyl-(1 → 6)-β-d-glucopyranosyl-(1 → 4)-β-d-fucopyranosyl (22S,24Z)-cycloart-24-en-3β,22,26-triol 26-O-(6-O-acetyl)-β-d-glucopyranoside (1), 3-O-α-l-arabinopyranosyl-(1 → 6)-β-d-glucopyranosyl-(1 → 4)-β-d-fucopyranosyl (22S,24Z)-cycloart-24-en-3β,22,26-triol 26-O-(6-O-acetyl)-β-d-glucopyranoside (2), 3-O-β-d-glucopyranosyl (24S)-cycloartane-3β,16β,24,25,30-pentaol 25-O-β-d-glucopyranosyl-(1 → 6)-β-d-glucopyranoside (3) and 3-O-β-d-glucopyranosyl (24S)-cycloartane-3β,16β,24,25,30-pentaol 25-O-β-d-glucopyranosyl-(1 → 4)-β-d-glucopyranoside (4), were isolated from the aerial parts of Thalictrum fortunei. Their structures were established on the basis of extensive NMR and HR-ESI-MS analyses, along with acid hydrolysis.
Keywords: Thalictrum fortunei, Ranunculaceae, Cycloartane glycoside
Introduction
The plant Thalictrum fortunei S. Moore (Ranunculaceae) is mainly distributed throughout southeastern China. The aerial part of this plant has been used in traditional Chinese medicine for the treatment of ophthalmia, dysentery and jaundice [1, 2]. In our previous study, several new cycloartane glycosides were isolated from this plant [3–5]. Further investigation on the aerial parts of the plant has led to the isolation of four new saponins (1–4) (Fig. 1), whose structures were determined with the aid of NMR, HR-ESI-MS and acid hydrolysis. Herein, we report the isolation and structural elucidation of these new compounds.
Fig. 1.
Chemical structures of 1–4
Results and discussion
Compound 1 was obtained as a white powder. Positive results from both Liebermann–Burchard and Molisch reactions indicated that 1 was a saponin. The molecular formula of 1 was C55H90O22 as determined from the quasimolecular ion [M−H]− at m/z 1101.5763 (calcd for C55H89O22: 1101.5846) in its HR-ESI mass spectrum. Acid hydrolysis of 1 afforded d-glucose, d-xylose and d-fucose, which were determined by gas chromatography analysis. The 1H NMR spectrum of 1 exhibited two doublet signals at δ 0.21 and 0.48 (each 1H, d, J = 3.8 Hz), which are characteristic for a cyclopropane moiety [6]. In addition, the signals for six tertiary methyls at δ 0.85, 1.00, 1.03, 1.28, 1.92 and 1.99 (each 3H, s), two secondary methyls at δ 1.16 (3H, d, J = 6.6 Hz) and 1.69 (3H, d, J = 6.1 Hz), as well as four anomeric protons at δ 4.66 (1H, d, J = 7.5 Hz), 4.85 (1H, d, J = 7.8 Hz), 4.95 (1H, d, J = 7.6 Hz) and 5.11(1H, d, J = 7.8 Hz) were observed. The 13C NMR and DEPT spectra displayed 55 carbon signals, including two olefinic carbons (δ 128.5 and 133.2) and four anomeric carbons (δ 106.9, 106.6, 106.0 and 102.8). With the aid of 1H–1H COSY, HSQC, HMBC and ROESY experiments (Fig. 2), all the 1H and 13C NMR signals of 1 were assigned as shown in Tables 1 and 2. A comparison of the NMR data of 1 with those of the known compound 3-O-β-d-glucopyranosyl-(1 → 4)-β-d-fucopyranosyl (22S,24Z)-cycloart-24-en-3β,22,26-triol 26-O-β-d-glucopyranoside revealed that their NMR signals were very similar, except for the appearance of the signals for additional acetyl and xylose units in 1, indicating that the aglycone of 1 is (22S,24Z)-cycloart-24-en-3β,22,26-triol [3]. The linkage sequence and positions of sugar moieties were determined by an HMBC experiment. Hence, in the HMBC spectrum, correlations between H-1 (δ 4.95) of xylose and C-6 (δ 70.0) of glucose, between H-1 (δ 5.11) of glucose and C-4 (δ 83.0) of fucose, between H-1 (δ 4.66) of fucose and C-3 (δ 88.6) of aglycone, as well as between H-1′ (δ 4.85) of another glucose and C-26 (δ 67.4) of aglycone, as well as between H-6′ (δ 4.73) of the glucose and carbonyl (δ 170.9) of the acetyl group were clearly observed. Therefore, the structure of 1 was identified as 3-O-β-d-xylopyranosyl-(1 → 6)-β-d-glucopyranosyl-(1 → 4)-β-d-fucopyranosyl (22S,24Z)-cycloart-24-en-3β,22,26-triol 26-O-(6-O-acetyl)-β-d-glucopyranoside.
Fig. 2.
Key ROESY correlations of compound 1
Table 1.
13C NMR data of 1–4 (pyridine-d 5)
| 1 | 2 | 3 | 4 | 1 | 2 | 3 | 4 | ||
|---|---|---|---|---|---|---|---|---|---|
| 1 | 32.2 | 31.1 | 32.0 | 32.0 | 4 | 71.5 | 70.6 | 71.7 | 71.8 |
| 2 | 30.0 | 28.9 | 30.2 | 29.9 | 5 | 77.4 | 76.1 | 78.4 | 78.2 |
| 3 | 88.6 | 87.4 | 89.3 | 89.3 | 6 | 70.0 | 68.7 | 62.7 | 62.9 |
| 4 | 41.3 | 40.2 | 45.0 | 45.0 | Glc′ 1′ | 102.8 | 101.7 | 97.6 | 97.6 |
| 5 | 48.0 | 46.9 | 47.8 | 47.7 | 2′ | 75.3 | 74.1 | 75.4 | 75.4 |
| 6 | 21.2 | 20.0 | 21.9 | 21.8 | 3′ | 78.7 | 77.3 | 78.8 | 78.7 |
| 7 | 26.2 | 25.1 | 26.7 | 26.5 | 4′ | 71.4 | 70.3 | 71.6 | 82.7 |
| 8 | 47.7 | 46.5 | 48.8 | 48.4 | 5′ | 78.4 | 77.3 | 77.5 | 78.0 |
| 9 | 20.1 | 18.9 | 21.1 | 21.2 | 6′ | 64.8 | 63.7 | 70.2 | 62.7 |
| 10 | 26.4 | 25.2 | 25.6 | 25.5 | Glc″ 1″ | 105.5 | 106.8 | ||
| 11 | 26.7 | 25.6 | 26.2 | 26.3 | 2″ | 75.2 | 75.5 | ||
| 12 | 33.4 | 32.3 | 33.2 | 33.0 | 3″ | 78.4 | 78.5 | ||
| 13 | 45.5 | 44.3 | 45.6 | 45.7 | 4″ | 71.8 | 71.6 | ||
| 14 | 49.0 | 48.0 | 46.8 | 46.9 | 5″ | 78.3 | 78.0 | ||
| 15 | 35.9 | 34.7 | 48.9 | 48.0 | 6″ | 62.7 | 62.9 | ||
| 16 | 28.0 | 26.9 | 71.6 | 71.7 | Fuc 1 | 106.9 | 105.8 | ||
| 17 | 49.1 | 48.0 | 57.6 | 57.7 | 2 | 73.5 | 72.4 | ||
| 18 | 18.3 | 17.2 | 19.6 | 19.6 | 3 | 75.7 | 74.6 | ||
| 19 | 29.7 | 28.6 | 29.9 | 30.3 | 4 | 83.0 | 82.0 | ||
| 20 | 41.7 | 40.5 | 29.4 | 29.5 | 5 | 70.4 | 69.3 | ||
| 21 | 12.1 | 11.0 | 18.2 | 17.6 | 6 | 17.9 | 16.8 | ||
| 22 | 73.0 | 71.8 | 33.8 | 34.0 | Xyl 1 | 106.0 | |||
| 23 | 35.0 | 33.8 | 28.4 | 28.8 | 2 | 74.9 | |||
| 24 | 128.5 | 127.5 | 74.8 | 74.9 | 3 | 78.1 | |||
| 25 | 133.2 | 132 | 80.5 | 80.7 | 4 | 71.2 | |||
| 26 | 67.4 | 66.3 | 22.9 | 22.8 | 5 | 67.0 | |||
| 27 | 22.2 | 21.0 | 22.5 | 22.4 | Ara 1 | 104.4 | |||
| 28 | 19.6 | 18.5 | 20.3 | 20.4 | 2 | 71.2 | |||
| 29 | 25.8 | 24.7 | 21.2 | 21.0 | 3 | 73.1 | |||
| 30 | 15.4 | 14.3 | 63.3 | 63.3 | 4 | 67.9 | |||
| Glc 1 | 106.6 | 105.5 | 106.1 | 106.2 | 5 | 65.3 | |||
| 2 | 75.8 | 74.6 | 75.5 | 75.6 | OAc | 170.9 | 167.9 | ||
| 3 | 78.6 | 77.5 | 78.7 | 78.5 | 21.0 | 20.8 |
Glc β-d-glucopyranose, Fuc β-d-fucopyranose, Xyl β-d-xylopyranose, Ara α-l-arabinopyranose
Table 2.
1H NMR data of saccharide moieties for 1–4 (pyridine-d 5, δ, J in Hz)
| 1 | 2 | 3 | 4 | ||
|---|---|---|---|---|---|
| Glc 1 | 5.11 (d, 7.8) | 5.09 (d, 7.7) | Glc 1 | 4.99 (d, 7.8) | 5.02 (d, 7.8) |
| 2 | 3.90 (dd, 7.8, 9.0) | 3.98 (dd, 7.7, 9.2) | 2 | 3.94 (dd, 7.8, 9.0) | 3.90 (dd, 7.8, 9.1) |
| 3 | 4.10 | 4.12 | 3 | 4.17 | 4.10 |
| 4 | 4.15 | 4.02 | 4 | 4.19 | 4.16 |
| 5 | 3.96 | 3.94 | 5 | 3.85 | 3.98 |
| 6a | 4.72 (br d, 11.4) | 4.72 (br d, 9.6) | 6a | 4.44 (dd, 11.8, 2.5) | 4.49 (dd, 11.8, 2.5) |
| 6b | 4.26 (dd, 11.4, 4.3) | 4.21 (dd, 9.6, 4.5) | 6b | 4.28 (dd, 11.8, 5.3) | 4.32 (dd, 11.8, 5.3) |
| Glc′ 1′ | 4.85 (d, 7.8) | 4.80 (d, 7.8) | Glc′ 1′ | 5.09 (d, 7.8) | 5.17 (d, 7.8) |
| 2′ | 4.00 (dd, 7.8, 9.2) | 3.98 (dd, 7.8, 9.0) | 2′ | 3.93 (dd, 7.8, 9.0) | 3.88 (dd, 7.8, 9.2) |
| 3′ | 4.20 | 4.12 | 3′ | 4.19 | 4.16 |
| 4′ | 4.21 | 4.10 | 4′ | 4.14 | 4.36 |
| 5′ | 4.04 | 4.03 | 5′ | 4.11 | 3.83 |
| 6a′ | 4.92 (br d, 11.9) | 4.92 (br d, 11.9) | 6a′ | 4.82 (br d, 11.8) | 4.38 (br d, 11.8) |
| 6b′ | 4.73 (dd, 11.9, 4.3) | 4.74 (dd, 11.9, 4.3) | 6b′ | 4.29 (dd, 11.8, 2.5) | 4.25 (dd, 11.8, 5.2) |
| Fuc 1 | 4.66 (d, 7.5) | 4.66 (d, 7.5) | Glc″ 1″ | 5.16 (d, 7.7) | 4.66 (d, 7.6) |
| 2 | 4.27 (dd, 7.5, 8.0) | 4.27 (dd, 7.5, 8.0) | 2″ | 4.03 (dd, 7.7, 9.0) | 3.83 (dd, 7.6, 9.0) |
| 3 | 3.98 | 3.98 | 3″ | 3.94 | 4.10 |
| 4 | 4.01 | 3.99 | 4″ | 4.05 | 4.13 |
| 5 | 3.71 (dq, 13.2, 6.4) | 3.72 (dq, 13.3, 6.5) | 5″ | 3.85 | 3.83 |
| 6 | 1.69 (d, 6.4) | 1.69 (d, 6.5) | 6a″ | 4.51 (br d, 11.8) | 4.38 (br d, 11.8) |
| Xyl/Ara | 4.95 (d, 7.6) | 4.89 (d, 6.5) | 6b″ | 4.34 (dd, 11.8, 2.5) | 4.25 (dd, 11.8, 2.5) |
| 2 | 4.00 | 4.41 (dd, 6.5, 6.8) | |||
| 3 | 3.90 | 4.09 | |||
| 4 | 4.10 | 4.22 | |||
| 5a | 4.27 (d, 11.3) | 4.18 | |||
| 5b | 3.63 (dd, 11.3, 10.0) | 3.68 | |||
| OAc | 1.99 (s) | 1.99 (s) |
Glc β-d-glucopyranose, Fuc β-d-fucopyranose, Xyl β-d-xylopyranose, Ara α-l-arabinopyranose
Compound 2 was obtained as a white powder. Positive results from both Liebermann–Burchard and Molisch reactions indicated that 2 was a saponin. The molecular formula of 2 was determined to be C55H90O22 by HR-ESI-MS (m/z 1101.5763 [M−H]−; calcd for C55H89O22: 1101.5846). Acid hydrolysis of 2 afforded d-glucose, l-arabinose and d-fucose. The 1H NMR spectrum of 2 showed signals for a cyclopropane unit at δ 0.20 and 0.45 (each 1H, d, J = 3.8 Hz), six tertiary methyls at δ 0.85, 0.99, 1.03, 1.28, 1.91 and 1.99 (each 3H, s), two secondary methyls at δ 1.16 (3H, d, J = 6.6 Hz) and 1.69 (3H, d, J = 7.3 Hz), as well as four anomeric protons at δ 4.66 (1H, d, J = 7.5 Hz), 4.80 (1H, d, J = 7.8 Hz), 4.89 (1H, d, J = 6.5 Hz) and 5.09 (1H, d, J = 7.7 Hz), indicating that 2 was also a cycloartane glycoside. Comparison of the 13C NMR data of 2 with those of 1 revealed that they possessed the same aglycone, but the signals of the xylose in 1 were replaced by those of an arabinose (δ 104.4, 73.1, 71.2, 67.9, 65.3) [3, 7] (Table 1). The linkage sequence and positions of sugar moieties were confirmed by the HMBC correlations between H-1 (δ 4.89) of arabinose and C-6 (δ 68.7) of glucose, between H-1 (δ 5.09) of glucose and C-4 (δ 82.0) of fucose, between H-1 (δ 4.66) of fucose and C-3 (δ 87.4) of aglycone, as well as between H-1′ (δ 4.80) of another glucose and C-26 (δ 66.3) of aglycone. These findings led to the assignment of 2 as 3-O-α-l-arabinopyranosyl-(1 → 6)-β-d-glucopyranosyl-(1 → 4)-β-d-fucopyranosyl (22S,24Z)-cycloart-24-en-3β,-22,-26-triol 26-O-(6-O-acetyl)-β-d-glucopyranoside.
Compound 3 was obtained as a white powder. Positive results from both Liebermann–Burchard and Molisch reactions indicated the compound was a saponin. The molecular formula was determined to be C48H82O20 by HR-ESI-MS (m/z 977.5340 [M−H]−; calcd for C48H81O20: 977.5321). Acid hydrolysis of 3 afforded d-glucose. The 1H NMR spectrum showed two doublet signals at δ 0.23 and 0.45 (each 1H, d, J = 3.8 Hz), which is characteristic for a cyclopropane moiety. Furthermore, signals for three anomeric protons at δ 4.99 (1H, d, J = 7.8 Hz), 5.09 (1H, d, J = 7.8 Hz) and 5.16 (1H, d, J = 7.7 Hz), five tertiary methyls at δ 0.81, 1.34, 1.43, 1.49 and 1.53 (each 3H, s), and a secondary methyl at δ 1.06 (3H, d, J = 6.6 Hz) were observed. Comparison of the 13C NMR spectrum of 3 with those of the known compound 3-O-β-d-glucopyranosyl (24S)-cycloartane-3β,16β,24,25,30-pentaol 25-O-β-d-glucopyranoside [4] indicated that the aglycone of 3 was 24S-cycloartane-3β,16β,24,25,30-pentaol (cyclofoetigenin B, a known compound) [8, 9], which was further confirmed by the 1H–1H COSY, HSQC, HMBC and ROESY data. The sequence and linkage positions of the sugar moieties were determined by an HMBC experiment. In the HMBC spectrum, correlations between H-1(δ 4.99) of glucose and C-3 (δ 89.3) of aglycone, between H-1″ (δ 5.16) of the outer glucose and C-6′ (δ 70.2) of the inner glucose, as well as between H-1′ (δ 5.09) of the inner glucose and C-25 (δ 80.5) were observed. On the basis of the above evidence, the structure of 3 was established as 3-O-β-d-glucopyranosyl (24S)-cycloartane-3β,16β,24,25,30-pentaol 25-O-β-d-glucopyranosyl-(1 → 6)-β-d-glucopyranoside.
Compound 4 was obtained as a white powder. Positive results from both Liebermann–Burchard and Molisch reactions indicated that 4 was a saponin. The molecular formula was determined to be C48H82O20 by HR-ESI-MS (m/z 977.5348 [M−H]−; calcd for C48H81O20: 977.5321). Acid hydrolysis of 4 afforded d-glucose. The 1H-NMR spectrum also showed two doublet signals at δ 0.16 and 0.33 (each 1H, d, J = 3.8 Hz), which is characteristic for a cyclopropane unit. The 1H and 13C NMR data of 4 were similar to those of the reported compound 3-O-β-d-glucopyranosyl (24S)-24-O-acetyl-cycloartane-3β,16β,24,25,30-pentaol 25-O-β-d-glucopyranosyl-(1 → 4)-β-d-glucopyranoside [4], except that the signals due to the acetyl moiety were absent in 4. The 1H and 13C NMR data (Tables 1, 2) were assigned by a combination of 1H–H COSY, HSQC, HMBC and ROESY experiments. The sequence and linkage positions of the sugar moieties were confirmed by an HMBC experiment. Hence, in the HMBC spectrum, the correlations between H-1 (δ 5.02) of glucose and C-3 (δ 89.3) of aglycone, between H-1″ (δ 4.66) of the outer glucose and C-4′ (δ 82.7) of the inner glucose, as well as between H-1′ (δ 5.17) of the inner glucose and C-25 (δ 80.7) of aglycone were observed. On the basis of the above evidence, the structure of 4 was established as 3-O-β-d-glucopyranosyl (24S)-cycloartane-3β,16β,24,25,30-pentaol 25-O-β-d-glucopyranosyl-(1 → 4)-β-d-glucopyranoside.
Experimental
General experimental procedures
Melting points were determined on an X-4 apparatus (Ningbo Hinotek Technology Ltd., Ningbo, China) and are uncorrected. Optical rotations were obtained using a Perkin-Elmer 241 polarimeter (Perkin-Elmer Ltd., Norwalk, USA). IR spectra were measured on a Nicolet Impact 410 FT-IR instrument (Nicolet Instrument Ltd., Madison, USA). UV spectra were recorded on a Shimadzu UV-2501 spectrophotometer (Shimadzu Ltd., Kyoto, Japan). The 1H and 13C NMR spectra were obtained on a Bruker AV500 Avance spectrometer (1H, 500 MHz; 13C, 125 MHz; Bruker Ltd., Karlsruhe, Germany) and chemical shifts are given in δ (ppm) with TMS as a reference. HR-ESI-MS data were obtained on an Applied Biosystems Mariner 5140 spectrometer (Life Technologies Ltd., New York, USA). Column chromatography (CC) was performed on silica gel (Qingdao Marine Chemical Ltd., Qingdao, China) and ODS (Merck Ltd., Darmstadt, Germany). Thin-layer chromatography was performed on precoated silica gel GF254 plates (Qingdao Marine Chemical Ltd., Qingdao, China). Preparative HPLC was carried out using a Zobax XDB-18 column (10 mm i.d. × 15 cm, Agilent Technologies Ltd., Wilmington DE, USA). GC experiments were carried out on an HP-1 TCD instrument (Hewlett-Packard Ltd., Palo Alto, USA) using an HP-Chiral column (30 m × 0.25 mm × 1.0 μm, 20 % permethylated β-cyclodextrin; Agilent Technologies Ltd., Wilmington DE, USA). All chemical reagents were purchased from Nanjing Reagent Co., Ltd. (Nanjing, China).
Plant material
The aerial parts of Thalictrum fortunei were collected in April of 2004 in Wuhu city, Anhui province of China, and were authenticated by Prof. Min-Jian Qin (China Pharmaceutical University). A voucher specimen (No. 040192) was deposited in the Herbarium of China Pharmaceutical University, Nanjing, People’s Republic of China.
Extraction and isolation
The dried aerial parts (4.8 kg) of T. fortunei were extracted with 95 % EtOH (3 × 20 L) under reflux. The EtOH extract was suspended in water and then successively extracted with petroleum ether, EtOAc and n-BuOH. The n-BuOH solution was concentrated to give a residue (207 g), which was separated by silica gel CC using CHCl3/MeOH (1:0 → 1:1, v/v) as eluent, affording five fractions (frs. 1–5). Fr 5 (889 mg) was further purified by ODS CC eluted with MeOH/H2O (70:30, v/v) and preparative HPLC using CH3CN/H2O (34:66, v/v) as solvent to yield compound 1 (25 mg, t R 7.3 min), 2 (30 mg, t R 9.8 min), 3 (17 mg, t R 17.9 min) and 4 (22 mg, t R 22.4 min).
3-O-β-d-Xylopyranosyl-(1 → 6)-β-d-glucopyranosyl-(1 → 4)-β-d-fucopyranosyl (22S,24Z)-cycloart-24-en-3β,22,26-triol 26-O-(6-O-acetyl)-β-d-glucopyranoside (1)
White powder, [α]
−25.8 (c 0.20, MeOH); mp: 232–233 °C; IR (KBr) v
max: 3465, 3414, 1603, 1387, 1360, 1120, 771, 625, 473 cm−1; HR-ESI-MS m/z: 1101.5763 [M−H]− (calcd for C55H89O22: 1101.5846); 1H NMR (pyridine-d
5): δ 0.48 (1H, d, J = 3.8 Hz, H-19a), 0.21 (1H, d, J = 3.8 Hz, H-19b), 0.85 (3H, s, Me-28), 1.00 (3H, s, Me-30), 1.03 (3H, s, Me-18), 1.16 (3H, d, J = 6.6 Hz, Me-21), 1.28 (3H, s, Me-29), 1.92 (3H, s, Me-27), 1.99 ((3H, s, OAc), 3.40 (1H, dd, J = 11.7, 4.3 Hz, H-3), 4.49, 4.70 (each 1H, ABq, J = 12.0 Hz, H-26a, -26b), 5.77 (1H, t, J = 7.2 Hz, H-24); 1H NMR data of the saccharide residues, see Table 2; 13C NMR data, see Table 1.
3-O-α-l-Arabinopyranosyl-(1 → 6)-β-d-glucopyranosyl-(1 → 4)-β-d-fucopyranosyl (22S,24Z)-cycloart-24-en-3β,22,26-triol 26-O-(6-O-acetyl)-β-d-glucopyranoside (2)
White powder, [α]
−6.9 (c 0.15, MeOH); mp: 223–224 °C; IR (KBr) v
max: 3427, 1604, 1381, 1118, 773, 624, 460 cm−1; HR-ESI-MS m/z: 1101.5763 [M−H]− (calcd for C55H89O22: 1101.5846); 1H NMR (pyridine-d
5): δ 0.45 (1H, d, J = 3.8 Hz, H-19a), 0.20 (1H, d, J = 3.8 Hz, H-19b), 0.85 (3H, s, Me-28), 0.99 (3H, s, Me-30), 1.03 (3H, s, Me-18), 1.16 (3H, d, J = 6.6 Hz, Me-21), 1.28 (3H, s, Me-29), 1.91 (3H, s, Me-27), 1.99 ((3H, s, OAc), 3.41 (1H, dd, J = 11.9, 4.1 Hz, H-3), 4.47, 4.70 (each 1H, ABq, J = 12.0 Hz, H-26a, -26b), 5.77 (1H, t, J = 7.2 Hz, H-24); 1H NMR data of the saccharide residues, see Table 2; 13C NMR data, see Table 1.
3-O-β-d-Glucopyranosyl (24S)-cycloartane-3β,16β,24,25,30-pentaol 25-O-β-d-glucopyranosyl-(1 → 6)-β-d-glucopyranoside (3)
White powder, [α]
+0.1 (c 1.01, MeOH); mp: 202–204 °C; IR (KBr) v
max: 3320, 2924, 2854, 1462, 1377, 1099, 1025 cm−1; HR-ESI-MS m/z: 977.5340 [M−H]− (calcd for C48H81O20: 977.5321); 1H NMR (pyridine-d
5): δ 0.23 (1H, d, J = 3.8 Hz, H-19a), 0.45 (1H, d, J = 3.8 Hz, H-19b), 0.81 (3H, s, Me-28), 1.06 (3H, d, J = 6.6 Hz, Me-21), 1.34 (3H, s, Me-18), 1.43 (3H, s, Me-27), 1.49 (3H, s, Me-26), 1.53 (3H, s, Me-29), 3.83 (1H, dd, J = 11.9, 4.3 Hz, H-3), 4.01 (1H, dd, J = 10.0, 1.7 Hz, H-24); 1H NMR data of the saccharide residues, see Table 2; 13C NMR data, see Table 1.
3-O-β-d-Glucopyranosyl (24S)-cycloartane-3β,16β,24,25,30-pentaol 25-O-β-d-glucopyranosyl-(1 → 4)-β-d-glucopyranoside (4)
White powder, [α]
+4.8 (c 1.00, MeOH); mp: 176–178 °C; IR (KBr) v
max: 3289, 2937, 1590, 1454, 1383, 1041 cm−1; HR-ESI-MS m/z: 977.5348 [M−H]− (calcd for C48H81O20: 977.5321); 1H NMR (pyridine-d
5): δ 0.33 (1H, d, J = 3.8 Hz, H-19a), 0.16 (1H, d, J = 3.8 Hz, H-19b), 0.80 (3H, s, Me-28), 1.00 (3H, d, J = 6.6 Hz, Me-21), 1.20 (3H, s, Me-18), 1.51 (3H, s, Me-27), 1.58 (3H, s, Me-26), 1.62 (3H, s, Me-29), 3.77 (1H, dd, J = 11.9, 4.3 Hz, H-3), 4.02 (1H, dd, J = 10.0, 1.8 Hz, H-24); 1H NMR data of the saccharide residues, see Table 2; 13C NMR data, see Table 1.
Acid hydrolysis
The solution of each compound (1–4, each 5 mg) in 30 mL of 1 M HCl (MeOH/H2O, 1:1, v/v) was heated under reflux for 3 h. After removal of the solvent, the residue was partitioned between CHCl3 and H2O. The aqueous layer was neutralized with Dowex (HCO3 −) and filtered. The filtrate was concentrated to 2 mL and then treated with NaBH4 (20 mg) at room temperature for 3 h. Excess NaBH4 was removed with 30 % AcOH. After evaporation at 60 °C and washing with 0.1 % HCl/MeOH, the mixture was dried at 105 °C for 15 min. After the addition of pyridine (0.5 mL) and Ac2O (0.5 mL), the mixture was incubated in a water bath at 100 °C for 1 h, and then partitioned between CHCl3 and H2O. The CHCl3 layer was concentrated for GC analysis (front inlet 250 °C, column temp. 80 °C → 230 °C, 5 °C/min)[10]. The peaks of each monosaccharide derivative were observed at t R (min): 1: d-glucose 33.079, d-fucose 27.829, d-xylose 28.810; 2: d-glucose 33.067, l-arabinose 28.293, d-fucose 27.835; 3: d-glucose 33.064; 4: d-glucose 33.071 (reference d-fucose 27.835, l-fucose 29.360, d-xylose 28.789, l-xylose 30.695, d-glucose 33.077, l-glucose 34.460, d-arabinose 29.862, l-arabinose 28.288).
Acknowledgments
This work was financially supported by Program for Changjiang Scholars and Innovative Research Team in University (IRT0965), National Natural Science Foundation of China (No. 81001384), and the Team Project of Natural Science Foundation of Guangdong Province (No. 8351063201000003).
Open Access
This article is distributed under the terms of the Creative Commons Attribution License which permits any use, distribution, and reproduction in any medium, provided the original author(s) and the source are credited.
Contributor Information
Xian-Tao Zhang, Email: zxtcpu@yahoo.com.cn.
Lei-Hong Zhang, Email: zhangleihong@163.com.
Wen-Cai Ye, Email: Chywc@yahoo.com.cn.
References
- 1.Ma ZQ, Xin SM, Shen XC. Antitumor effect and toxicity test of thalidasine. Chin Tradit Herb Drugs. 1980;11:217–219. [Google Scholar]
- 2.Wu ZX, Dong GP, Wu TB, Min ZD. Studies on the alkaloids from Thalictrumfortunei. Acta Bot Sin. 1990;32:210–212. [Google Scholar]
- 3.Zhang XT, Zhang LH, Ye WC, Zhang XL, Yin ZQ, Zhao SX, Yao XS. Four new cycloartane glycosides from Thalictrum fortunei. Chem Pharm Bull. 2006;54:107–110. doi: 10.1248/cpb.54.107. [DOI] [PubMed] [Google Scholar]
- 4.Sun H, Zhang XT, Wang L, Zhang XQ, Wang Y, Chen SB, Xiao PG, Ye WC. Four new cycloartane (9,19-cyclolanostane) saponins from the aerial parts of Thalictrum fortunei. Helv Chim Acta. 2008;91:1961–1966. doi: 10.1002/hlca.200890210. [DOI] [Google Scholar]
- 5.Zhang XT, Wang H, Yin ZQ, Ye WC, Zhao SX. Chemical constituents from Thalictrum fortunei. J China Pharm Univ. 2007;38:21–24. [Google Scholar]
- 6.Yoshimitsu H, Hayashi K, Shingu K, Kinjo J, Yahara S, Nakano K, Murakami K, Tomimatsu T, Nohara T. Two new cycloartane glycosides, thalictosides A and C from Thalictrum thunbergii D.C. Chem Pharm Bull. 1992;40:2465–2468. doi: 10.1248/cpb.40.2465. [DOI] [Google Scholar]
- 7.Ma WG, Mizutania M, Malterud KE, Lu SL, Ducrey B, Taharaa S. Saponins from the roots of Panax notoginseng. Phytochemistry. 1999;52:1133–1139. doi: 10.1016/S0031-9422(99)00364-7. [DOI] [Google Scholar]
- 8.Yu SC, Wu QL, Wang LW, Xiao PG. New triterpene glycoside from Thalictrum smithii. Chin Chem Lett. 1999;10:485–486. [Google Scholar]
- 9.Ganenko TV, Isaev MI, Gromova AS, Abdullaev ND, Lutskii VI, Larin MF, Semenov AA, Gorovits MB, Abubakirov NK. Triterpene glycosides and their genins from Thalictrum foetidum. IV. Structure of cyclofoetigenin B. Chem Nat Comp. 1986;22:288–294. doi: 10.1007/BF00598298. [DOI] [Google Scholar]
- 10.Zhou XL, He XJ, Wang GH, Gao H, Zhou GX, Ye WC, Yao XS. Steroidal saponins from Solanum nigrum. J Nat Prod. 2006;69:1158–1163. doi: 10.1021/np060091z. [DOI] [PubMed] [Google Scholar]